|
Nov 1
|
UPDATE 1-Bayer investor urges rethink after latest glyphosate defeat
|
|
Nov 1
|
Bayer investor urges rethink after latest glyphosate defeat
|
|
Oct 31
|
UPDATE 2-Bayer ordered to pay $332 mln in Roundup cancer trial
|
|
Oct 31
|
Bayer ordered to pay $332 million in Roundup cancer trial
|
|
Oct 31
|
Bayer ordered to pay $332 mln in Roundup cancer trial -Law.com
|
|
Oct 27
|
UPDATE 1-Bayer ordered to pay $175 mln in latest Roundup cancer trial
|
|
Oct 25
|
Bayer Aktiengesellschaft (ETR:BAYN) Delivered A Weaker ROE Than Its Industry
|
|
Aug 11
|
Pharma Stock Roundup: LLY, BAYRY Post Q2 Results, NVO's Wegovy Cuts Heart Attack Risk
|
|
Aug 10
|
Bayer is Using Unprecedented Insights in Unexpected Ways on the Farm
|
|
Aug 8
|
Bayer (BAYRY) Q2 Earnings Miss Estimates, '23 Outlook Lowered
|
|
Aug 8
|
Bayer Lowers Revenue Forecasts for Crops and Drugs Units
|
|
Aug 8
|
Bayer says guidance cut driven by Crop Science, Pharma
|